Enfusion (ENFN) Earnings Date, Estimates & Call Transcripts

$9.05
-0.21 (-2.27%)
(As of 05/10/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 9)
-$0.01 Missed By -$0.05
Consensus EPS
(May. 9)
$0.04
Skip Charts & View Estimated and Actual Earnings Data

ENFN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENFN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enfusion Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251$0.04$0.04$0.04 
Q2 20251$0.06$0.06$0.06 
Q3 20251$0.07$0.07$0.07 
Q4 20251$0.07$0.07$0.07 
FY 20254$0.24$0.24 $0.24

ENFN Earnings Date and Information

Enfusion last announced its quarterly earnings results on May 9th, 2024. The reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.05. The company earned $48.05 million during the quarter, compared to analyst estimates of $47.67 million. Enfusion has generated $0.03 earnings per share over the last year ($0.03 diluted earnings per share) and currently has a price-to-earnings ratio of 301.8. Earnings for Enfusion are expected to grow by 142.86% in the coming year, from $0.07 to $0.17 per share. Enfusion has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Enfusion Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
Estimated)
------- 
5/9/2024Q1 2024$0.04($0.01)($0.05)($0.01)$47.67 million$48.05 million    
3/12/2024Q4 2023$0.03$0.01($0.02)$0.01$45.56 million$46.49 million
11/7/2023Q3 2023$0.03$0.02($0.01)$0.02$43.95 million$44.36 million
8/8/2023Q2 2023$0.02$0.02-$0.03$44.58 million$42.72 million
5/9/2023Q1 2023$0.01$0.04+$0.03$0.04$41.99 million$40.97 million
3/7/2023Q4 2022-$0.01+$0.01$0.01$39.88 million$40.52 million
11/10/2022Q3 2022($0.03)$0.02+$0.05$0.02$38.52 million$39.15 million
8/9/2022Q2 2022($0.04)($0.03)+$0.01($0.03)$35.67 million$36.54 million
5/12/2022Q1 2022$0.04$0.03($0.01)$0.16$33.01 million$34.14 million
3/24/2022Q4 2021$0.04$0.55+$0.51$3.36$30.52 million$31.85 million    

Enfusion Earnings - Frequently Asked Questions

When is Enfusion's earnings date?

Enfusion has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ENFN's earnings history.

Did Enfusion beat their earnings estimates last quarter?

In the previous quarter, Enfusion (NYSE:ENFN) missed the analysts' consensus estimate of $0.04 by $0.05 with a reported earnings per share (EPS) of ($0.01). Learn more on analysts' earnings estimate vs. ENFN's actual earnings.

How can I listen to Enfusion's earnings conference call?

The conference call for Enfusion's latest earnings report can be listened to online. Listen to Conference Call

How can I read Enfusion's conference call transcript?

The conference call transcript for Enfusion's latest earnings report can be read online. Read Transcript

How much revenue does Enfusion generate each year?

Enfusion (NYSE:ENFN) has a recorded annual revenue of $174.54 million.

How much profit does Enfusion generate each year?

Enfusion (NYSE:ENFN) has a recorded net income of $6.03 million. ENFN has generated $0.03 earnings per share over the last four quarters.

What is Enfusion's price-to-earnings ratio?

Enfusion (NYSE:ENFN) has a trailing price-to-earnings ratio of 301.77 and a forward price-to-earnings ratio of 129.29. The price/earnings-to-growth ratio is 2.7.

What is Enfusion's EPS forecast for next year?

Enfusion's earnings are expected to grow from $0.07 per share to $0.17 per share in the next year, which is a 142.86% increase.


More Earnings Resources from MarketBeat

This page (NYSE:ENFN) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners